Why join us?

For the past two decades immunology has been one of the growth engines of the pharmaceutical industry, reliably delivering double-digit growth year in, year out.

However, this era of hypergrowth is coming to an end, and a rising tide will no longer lift all boats: Long-dominating, first-generation innovation is maturing; biosimilars are eroding the value of flagship brands, introducing low-cost backbone therapies, while many already served indications face extensive crowding as next-generation therapies jostle for position, often supported by huge promotional investments.

With immunology at an inflection point, our webinar comes at a critical time to review where unmet need and opportunities continue to exist to define the next era of this market.

This webinar will discuss the latest trends in immunology and how innovators need to re-focus – on under-served indications and patient populations, differentiation through new modalities, MoAs, orals and combination therapies – to capture future growth.

Key takeaways:

• Despite the immunology market’s increasing maturity, significant unmet need and opportunity still exist.
• Market expansion into underserved indications and patient segments is key to find growth.
• Winning in immunology requires sustained commitment, commercial precision, market shaping and building early advocacy, and increasingly comparative evidence.